Raymond Zhou

Project Title: Pre-clinical assessment of Glycan-dependent Immunotherapeutic molecules in mice

Immunotherapy using monoclonal antibodies has been recently developed as a promising approach to treat cancer. Alterations in the addition of carbohydrates to proteins is a near universal feature of cancer, but is not targeted by current immunotherapies. I currently examine the possibility of a novel technology that directs immune cells to kill cancer cells based on expression of altered carbohydrates.

Abstract

Section 1